skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 163  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
Material Type:
Article
Add to My Research

Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats

Journal of cellular and molecular medicine, 2020-01, Vol.24 (2), p.1760-1773 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14870 ;PMID: 31856386

Full text available

2
Alterations in cardiac DNA methylation in human dilated cardiomyopathy
Material Type:
Article
Add to My Research

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

EMBO molecular medicine, 2013-03, Vol.5 (3), p.413-429 [Peer Reviewed Journal]

Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO ;Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. ;2013. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO 2013 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.1002/emmm.201201553 ;PMID: 23341106

Full text available

3
FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway
Material Type:
Article
Add to My Research

FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway

Journal of cellular and molecular medicine, 2019-04, Vol.23 (4), p.2558-2567 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14146 ;PMID: 30701683

Full text available

4
Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
Material Type:
Article
Add to My Research

Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy

EMBO molecular medicine, 2015-05, Vol.7 (5), p.562-576 [Peer Reviewed Journal]

2015 The Authors. Published under the terms of the CC BY 4.0 license ;2015 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2015 John Wiley & Sons, Inc. ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Published under the terms of the CC BY 4.0 license 2015 ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201505047 ;PMID: 25759365

Full text available

5
Folic acid reduces doxorubicin‐induced cardiomyopathy by modulating endothelial nitric oxide synthase
Material Type:
Article
Add to My Research

Folic acid reduces doxorubicin‐induced cardiomyopathy by modulating endothelial nitric oxide synthase

Journal of cellular and molecular medicine, 2017-12, Vol.21 (12), p.3277-3287 [Peer Reviewed Journal]

2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13231 ;PMID: 28608983

Full text available

6
Novel polymorphisms in PDLIM3 and PDLIM5 gene encoding Z‐line proteins increase risk of idiopathic dilated cardiomyopathy
Material Type:
Article
Add to My Research

Novel polymorphisms in PDLIM3 and PDLIM5 gene encoding Z‐line proteins increase risk of idiopathic dilated cardiomyopathy

Journal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.7054-7062 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14607 ;PMID: 31424159

Full text available

7
Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1‐mediated activation of AMPK/Nrf2 signal molecules
Material Type:
Article
Add to My Research

Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1‐mediated activation of AMPK/Nrf2 signal molecules

Journal of cellular and molecular medicine, 2020-10, Vol.24 (20), p.12141-12153 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15859 ;PMID: 32918384

Full text available

8
Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy
Material Type:
Article
Add to My Research

Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy

Experimental physiology, 2018-12, Vol.103 (12), p.1593-1602 [Peer Reviewed Journal]

2018 The Authors. Experimental Physiology © 2018 The Physiological Society ;2018 The Authors. Experimental Physiology © 2018 The Physiological Society. ;2018 The Physiological Society ;ISSN: 0958-0670 ;EISSN: 1469-445X ;DOI: 10.1113/EP087189 ;PMID: 30311699

Full text available

9
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
Material Type:
Article
Add to My Research

Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation

Journal of cachexia, sarcopenia and muscle, 2016-12, Vol.7 (5), p.555-566 [Peer Reviewed Journal]

2016 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders ;2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12116 ;PMID: 27239419

Full text available

10
Reduction in mitochondrial iron alleviates cardiac damage during injury
Material Type:
Article
Add to My Research

Reduction in mitochondrial iron alleviates cardiac damage during injury

EMBO molecular medicine, 2016-03, Vol.8 (3), p.247-267 [Peer Reviewed Journal]

2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201505748 ;PMID: 26896449

Full text available

11
Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: Systematic review and meta‐analysis
Material Type:
Article
Add to My Research

Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: Systematic review and meta‐analysis

Annals of noninvasive electrocardiology, 2018-07, Vol.23 (4), p.e12533-n/a [Peer Reviewed Journal]

2018 Wiley Periodicals, Inc. ;2018 European Society of Cardiology and Wiley Periodicals, Inc. ;ISSN: 1082-720X ;EISSN: 1542-474X ;DOI: 10.1111/anec.12533 ;PMID: 29363882

Full text available

12
The Role of Biventricular Pacing in the Prevention and Therapy of Pacemaker-Induced Cardiomyopathy
Material Type:
Article
Add to My Research

The Role of Biventricular Pacing in the Prevention and Therapy of Pacemaker-Induced Cardiomyopathy

Annals of noninvasive electrocardiology, 2015-05, Vol.20 (3), p.224-239 [Peer Reviewed Journal]

2014 Wiley Periodicals, Inc. ;2015 European Society of Cardiology and Wiley Periodicals, Inc ;ISSN: 1082-720X ;EISSN: 1542-474X ;DOI: 10.1111/anec.12245 ;PMID: 25564929

Full text available

13
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
Material Type:
Article
Add to My Research

Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic

JAMA Network Open, 2020-07, Vol.3 (7), p.e2014780-e2014780 [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright 2020 Jabri A et al. . ;ISSN: 2574-3805 ;EISSN: 2574-3805 ;DOI: 10.1001/jamanetworkopen.2020.14780 ;PMID: 32644140

Full text available

14
Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy
Material Type:
Article
Add to My Research

Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy

Chinese medical journal, 2015-06, Vol.128 (11), p.1483-1489 [Peer Reviewed Journal]

COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd. ;COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd. ;Copyright Medknow Publications & Media Pvt. Ltd. Jun 5, 2015 ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;Copyright: © 2015 Chinese Medical Journal 2015 ;ISSN: 0366-6999 ;EISSN: 2542-5641 ;DOI: 10.4103/0366-6999.157656 ;PMID: 26021505

Full text available

15
Recent advances in genetic testing and counseling for inherited arrhythmias
Material Type:
Article
Add to My Research

Recent advances in genetic testing and counseling for inherited arrhythmias

Journal of arrhythmia, 2016-10, Vol.32 (5), p.389-397 [Peer Reviewed Journal]

Japanese Heart Rhythm Society ;2016 Japanese Heart Rhythm Society ;Copyright John Wiley & Sons, Inc. Oct 2016 ;2016 The Author 2016 ;ISSN: 1880-4276 ;EISSN: 1883-2148 ;DOI: 10.1016/j.joa.2015.12.009 ;PMID: 27761163

Digital Resources/Online E-Resources

16
Irisin inhibits high glucose‐induced endothelial‐to‐mesenchymal transition and exerts a dose‐dependent bidirectional effect on diabetic cardiomyopathy
Material Type:
Article
Add to My Research

Irisin inhibits high glucose‐induced endothelial‐to‐mesenchymal transition and exerts a dose‐dependent bidirectional effect on diabetic cardiomyopathy

Journal of cellular and molecular medicine, 2018-02, Vol.22 (2), p.808-822 [Peer Reviewed Journal]

2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;ISSN: 1582-4934 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13360 ;PMID: 29063670

Full text available

17
Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
Material Type:
Article
Add to My Research

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy

Journal of arrhythmia, 2017-10, Vol.33 (5), p.410-416 [Peer Reviewed Journal]

Japanese Heart Rhythm Society ;2017 Japanese Heart Rhythm Society ;Copyright John Wiley & Sons, Inc. Oct 2017 ;2017 Japanese Heart Rhythm Society. Published by Elsevier B.V. 2017 Japanese Heart Rhythm Society ;ISSN: 1880-4276 ;EISSN: 1883-2148 ;DOI: 10.1016/j.joa.2017.03.002 ;PMID: 29021842

Digital Resources/Online E-Resources

18
The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients
Material Type:
Article
Add to My Research

The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients

Annals of noninvasive electrocardiology, 2019-09, Vol.24 (5), p.e12672-n/a [Peer Reviewed Journal]

2019 Wiley Periodicals, Inc. ;2019 European Society of Cardiology and Wiley Periodicals, Inc. ;ISSN: 1082-720X ;EISSN: 1542-474X ;DOI: 10.1111/anec.12672 ;PMID: 31152489

Full text available

19
Identification of micro‐RNA networks in end‐stage heart failure because of dilated cardiomyopathy
Material Type:
Article
Add to My Research

Identification of micro‐RNA networks in end‐stage heart failure because of dilated cardiomyopathy

Journal of cellular and molecular medicine, 2013-09, Vol.17 (9), p.1173-1187 [Peer Reviewed Journal]

2013 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright Blackwell Publishing Ltd. Sep 2013 ;2013. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine 2013 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12096 ;PMID: 23998897

Full text available

20
MiR‐451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1
Material Type:
Article
Add to My Research

MiR‐451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1

Journal of cellular and molecular medicine, 2014-11, Vol.18 (11), p.2266-2274 [Peer Reviewed Journal]

2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2014 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2014 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12380 ;PMID: 25209900

Full text available

Results 1 - 20 of 163  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2003  (5)
  2. 2003 To 2008  (13)
  3. 2009 To 2013  (50)
  4. 2014 To 2019  (64)
  5. After 2019  (31)
  6. More options open sub menu

Searching Remote Databases, Please Wait